Literature DB >> 19070454

Combination of different molecular mechanisms leading to fluconazole resistance in a Candida lusitaniae clinical isolate.

David Reboutier1, Mathieu Piednoël, Stéphanie Boisnard, Audrey Conti, Virginie Chevalier, Martine Florent, Stéphanie Gibot-Leclerc, Bruno Da Silva, Christiane Chastin, Karim Fallague, Anne Favel, Thierry Noël, Gwenaël Ruprich-Robert, Florence Chapeland-Leclerc, Nicolas Papon.   

Abstract

We report on the underlying molecular mechanisms likely responsible for the high-level fluconazole resistance in a Candida lusitaniae clinical isolate. Fluconazole resistance correlated with overexpression of ERG11 and of several efflux pump genes, in particular, the orthologs of the Candida albicans MDR1, PDR16, CDR1, CDR2, and YOR1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070454     DOI: 10.1016/j.diagmicrobio.2008.10.019

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

1.  Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.

Authors:  Sandra A Asner; Stefano Giulieri; Manuel Diezi; Oscar Marchetti; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

2.  Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole.

Authors:  Frédéric Gabriel; Ayman Sabra; Sofiane El-Kirat-Chatel; Sophie Pujol; Valérie Fitton-Ouhabi; Daniel Brèthes; Karine Dementhon; Isabelle Accoceberry; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  Cryptococcus neoformans releases proteins during intracellular residence that affect the outcome of the fungal-macrophage interaction.

Authors:  Eric H Jung; Yoon-Dong Park; Quigly Dragotakes; Lia S Ramirez; Daniel Q Smith; Flavia C G Reis; Amanda Dziedzic; Marcio L Rodrigues; Rosanna P Baker; Peter R Williamson; Anne Jedlicka; Arturo Casadevall; Carolina Coelho
Journal:  Microlife       Date:  2022-09-21

4.  New diphenylphosphane derivatives of ketoconazole are promising antifungal agents.

Authors:  Rodrigo F M de Almeida; Filipa C Santos; Krzysztof Marycz; Michalina Alicka; Anna Krasowska; Jakub Suchodolski; Jarosław J Panek; Aneta Jezierska; Radosław Starosta
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

5.  Carveoylphenols and Their Antifungal Potential against Pathogenic Yeasts.

Authors:  Iván Montenegro; Marco Mellado; Alessandra Russo; Bastian Said; Ximena Besoain; Patricio Godoy; Enrique Werner; Nelson Caro; Alejandro Madrid
Journal:  Antibiotics (Basel)       Date:  2019-10-15

6.  Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae.

Authors:  Abhilash Kannan; Sandra A Asner; Emilie Trachsel; Steve Kelly; Josie Parker; Dominique Sanglard
Journal:  mBio       Date:  2019-12-24       Impact factor: 7.867

7.  Balancing Positive and Negative Selection: In Vivo Evolution of Candida lusitaniae MRR1.

Authors:  Elora G Demers; Jason E Stajich; Alix Ashare; Patricia Occhipinti; Deborah A Hogan
Journal:  mBio       Date:  2021-03-30       Impact factor: 7.867

8.  Evolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infection.

Authors:  Elora G Demers; Amy R Biermann; Sawyer Masonjones; Alex W Crocker; Alix Ashare; Jason E Stajich; Deborah A Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-02       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.